Startups

Mubadala Investment Company Announces Its Largest Healthcare Investment in the U.S

Mubadala Investment Company, one of Abu Dhabi’s leading sovereign investors, has completed a deal to acquire a minority stake in Zelis, a U.S.-based provider of advanced technological solutions in the healthcare sector. This marks Mubadala’s largest investment in healthcare to date, underscoring the company’s commitment to expanding its footprint in this vital field.

Investment Details and Key Partners

Mubadala led the investment with the participation of prominent investors, including:

  • Norwest
  • HarbourVest

Meanwhile, Parthenon and Bain Capital will remain the principal owners of Zelis.

Mubadala’s Vision for Healthcare Investment

Mina Hamoodi, Head of Healthcare Investments at Mubadala, stated:

“Zelis delivers integrated solutions that simplify the complex financial systems in the U.S. healthcare sector. With its innovative technologies, Zelis enhances efficiency and outcomes for all stakeholders within this space.”

She further emphasized that this step represents a strategic shift for Mubadala into technologies that serve both healthcare providers and recipients—a key focus within the company’s broader investments in healthcare IT.

Zelis: Revolutionizing Healthcare Efficiency

Zelis serves over 750 payers, including:

  • The five largest national health plans in the U.S.
  • Insurance companies under the BCBS Association.
  • Third-party administrators (TPAs).
  • Millions of providers and consumers.

The company offers comprehensive tech-driven solutions designed to address systemic challenges and improve overall performance in healthcare. By reducing costs and enhancing outcomes, Zelis is helping transform the healthcare ecosystem.

Amanda Eisel, CEO of Zelis, commented:

“We are thrilled to partner with Mubadala and our new investors to drive greater efficiency and deliver meaningful impact across the U.S. healthcare system.”

Transaction Advisors and Closing Date

Leading financial and legal firms played key roles in finalizing this transaction:

  • Goldman Sachs and J.P. Morgan acted as financial advisors to Zelis.
  • Kirkland & Ellis LLP served as legal counsel for Zelis.
  • Evercore acted as financial advisor to Mubadala.
  • Akin Gump Strauss Hauer & Feld LLP served as legal counsel to Mubadala.

The transaction officially closed on November 26, 2024.

Future Outlook

This investment highlights Mubadala’s commitment to advancing global healthcare systems through innovative technological solutions. It reflects the company’s strategic focus on enhancing inclusivity and efficiency in the healthcare sector while fostering strong partnerships with industry leaders.

Related Articles

Back to top button